The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8828966 B1

PDF
Full Text
Expired
Date of Patent:
Sep. 09, 2014

Filed:

Apr. 27, 2012
Applicants:

Claire Mitchell, Philadelphia, PA (US);

Alan Laties, Philadelphia, PA (US);

Inventors:

Claire Mitchell, Philadelphia, PA (US);

Alan Laties, Philadelphia, PA (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/70 (2006.01); A61K 31/44 (2006.01); A61K 31/185 (2006.01); A61K 31/47 (2006.01); C40B 30/06 (2006.01); C12N 5/07 (2010.01); A61K 31/7076 (2006.01); A61K 31/137 (2006.01); G01N 33/84 (2006.01); A61K 45/06 (2006.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
A61K 31/137 (2013.01); A61K 31/7076 (2013.01); G01N 33/84 (2013.01); A61K 45/06 (2013.01); G01N 33/5044 (2013.01);
Abstract

Provided is a method of treating or preventing age-related macular degeneration (AMD) in a patient subject to, or symptomatic of the disease, wherein the method comprises restoring normal lysosomal pH (pH), or acidifying an abnormally elevated pH, thus decreasing or preventing a damaging accumulation of lipofuscin or waste products in the retinal pigment epithelium (RPE) cells of the eye of the patient. Further, this method is achieved by modulating the action of the P2X7 and/or P2Y12 receptors of the RPE cells, specifically decreasing the acidity (pH) of the RPE lysosomes by administering selected receptor antagonists affecting the action of the P2X7 and/or P2Y12 receptors of the RPE. Methods for selecting and quantifying the effectiveness of drugs to restore pHand determine outer segment clearance rates is also provided using a high through-put screening protocol.


Find Patent Forward Citations

Loading…